>From bettym19@mindspring.comSat Dec 23 18:41:31 1995 Date: Sat, 23 Dec 1995 16:34:12 -0500 From: Betty Martini Newsgroups: misc.health.diabetes Subject: Aspartame/diabetes/references continued Dear James: This continues the references from the article NEUROTOXIC POTENTIAL OF ASPARTAME dealing with independent testing of aspartame. Also contains citations. 31. Blundell, J.E.: Hill, A.H. "Paradoxical Effects of an Intense Sweetener (Aspartame) on Appetite." The Lancet (May 10, l986) pp. l092-1093. 32. Garriga, M., MD; and Metcalf, D.,MD. "Aspartame intolerance" Annals of Allergy 61:63-66 (December 1988) 33. United States General Accounting Office/HRD-87-86, Food and Drug Administration's Approval of Aspartame. (June l987) 34. Council Report: Aspartame review of safety issues. Journal of the American Medical Association l985:254 (3):400 35. Johns,D.R., MD, Letter to the Editor. The New England Journal of Medicine (August 14, 1986) 36. Novick, N.J. "Aspartame-induced granulomatous panniculitis." Annals of Internal Medicine 102:206-207 (l985) 37. McCauliffe, D.: and Poitras, K. "Aspartame-induced lobular panniculitis." J of the American Academy of Dermatology 24 (2):298-299 (February 1991) 38. Kulezycki,A.Jr. "Aspartame induced urticaria. Annals of Internal Medicine 104:207-208 (l986) 39. Wurtman, R.J. "Aspartame: possible effect on seizure susceptibility." Lancet 2:1060. (l985) 40. Schainker, N. and Olney, J.W. "Glutamate Type Hypothalamic Pituitary Syndrome in Mice Treated with Aspartame or Cysteate in Infancy." Journal of Neutral Trans. 35: 207-215 (l974) 41. Reynolds, W. A.: Butler, V." Lemley-Johnson, N. "Hypothalamic Morphology Following ingestion of Aspartame of MSG in the Neonatal Rodent and Primate: A Preliminary Report" Journal of Toxicology and Environmental Health 2:471-480 (l976) 42. Pizzi, W.J.:Tabor, J.M.:Barnhart,J. "Somatic, Behavioral and Reproductive Disturbances in Mice Following Neonatal Administration of Sodium L-Aspartate." Pharmacological Biochemical Behavior 9::481-485 (l976) 43. Stegnik, L.D.: Brummel, M.C.; et al, "Blood Methanol Concentrations in Normal Adult Subjects Administered Abuse dose of Aspartame." J of Toxicological Environmental Health 7:281-290 (l981) 44. Monte, Woodrow, "Aspartame: Methanol and the Public Health," Journal of Applied Nutrition 36(1):42-54 (l984). 45. Bergeron, R.:Cardinal, J." et al. "Prevention of Methanol Toxicity by Ethanol Therapy." New England Journal of Medicine (December 9, 1982) pp. 1528 46. Tsang, W.S.;Clarke, M.A.; Parrish, F.W. "Determination of Aspartame and Its Breakdown Products in Soft Drinks by Reverse-Phase Chromatography with UV Detection." Journal of Agricultural Fd. Chemicals 33:734-738 (l985) 47. Davoli, E.; Cappeilini, L.' et al. "Serum Methanol Concentrations in Rats and in Men after a Single Dose of Aspartame." Fed. Chemical Toxicology 24 (3):187-189 (l986). 48. Uribe, M. "Potential Toxicity of a New Sugar Substitute in Patients with Liver Disease." New England Journal of Medicine. 306 (3):173-174 (Jan 21, 1981). 49. Wurtman, R.J. "Neurochemical Changes Following High Dose Aspartame with Dietary Carbohydrates." New England Journal of Medicine 309:7 (August 18, 1982). 50. Sharma, R.P.; Coulombe, R.A., Jr. "Effects of Repeated Doses of Aspartame on Serotonin and its Metabolite in Various Regions of the Mouse Brain." Toxicology Program, Department of Animal, Dairy and Veterinary Sciences. Utah State University. (l986). 51. Young, S.N.: Smith, S.E.; et al. "Tryptophan Depletion Causes a Rapid Lowering of Mood in Normal Males." Psychopharmocology. 87: 173-177 (l985). 52. Padridge, W.M. "The Safety of Aspartame." J of the American Medical Association 256 (19):2678. (November 21, l986). 53. Roberts, H.J. "New Perspectives Concerning Alzheimer's Disease." On Call (August 1989) pp. 14-16 54. Walton, R.G.: Hudak, R.: and Green-Waite, R.J. "Adverse REactions to Aspartame: Double-blind Challenge in Patients from a Vulnerable Population." Biological Psychiatary pp. 13-17 (l993). 55. Lipton, S.A.: Rosenberg, P.A. "Excitatory Amino Acids as a Final common Pathway for Neurologic Disorders." New England Journal of Medicine 330 (9):613-622 (l994). 56. Dow-Edwards, D." Scribani, L.: and Riley, E.P. "Impaired Performance on Odor-Aversion Testing Follow Prenatal Aspartame Exposure in the Guinea Pig." Neurotoxicology and Teratoiogy 11:413-416 (l989). 57. Millstone, E. "Sweet and Sour: The Unanswered Questions about Aspartame." The Scoiogist Volume 24, Number 2 (March/April 1994). It should be noted that the study by Dr. Diana Dow-Edwards was originally funded by the NutraSweet Company. When she got disastrous results they withdrew their funding and Dr. Dow-Edwards had to pay for the study herself. Then the NutraSweet Company refused to accept it. You wanted independent studies and here are some of them. Remember that indictment was sought for fraud on ones funded by Searle. U.S. Attorney Sam Skinner went to work for Searle's law firm defending the case rather than indicting them. Had he done what was asked NutraSweet would probably not be in the market today. Cynthia Crossen in her book THE TAINTED TRUTH; THE MANIPULATION OF FACT IN AMERICA, says "The read to hell was paved with the flood of corporate research dollars which in 1991 had burgeoned to over $2.1 billion. Researchers are working for people who don't like negative findings and who aren't likely to fund further research by those who produce them. .." "In today's corporate-dominated information market truth has become to belong to those who commission it." So now you get to decide if you want to use a sweetener that in reality is a deadly drug that has caused grand mal seizures, brain tumors and other cancers, 92 documented symptoms listed by the FDA, disability and death, blindness, birth defects, Alzheimers and is deadly for diabetics! For those who don't there a safe sweetener list and resource guide on our auto-responder below the signature line. For those who want more information on the politics and "flawed tests" funded by Searle check Mark Gold's web page: http://www.tiac.net/users/mgold/health.html Betty Martini Mission Possible International 9270 State Bridge Road Suite 215 Duluth, Georgia 30097 Email: bettym19@mindspring.com